MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sale of
convertible bond
$2,172K
Net cash flows
provided by investing...
$2,171K
Effect of exchange rate
changes on cash
$3K
Canceled cashflow
$1K
Net increase
(decrease) in cash and cash...
$738K
Canceled cashflow
$1,436K
Purchases of property and
equipment
$1K
Proceeds from notes
payable issued
$7,908K
Accounts payable and
accrued expenses
$6,456K
Loss on debt
extinguishment
-$1,363K
Amortization of discount of
notes payable and...
$560K
Realized loss on
investment in convertible...
-$531K
Other non-current
assets
-$323K
Inventory reserve
-$111K
Depreciation and
amortization
$39K
Share-based compensation
$25K
Change in fair value of
warrant derivative...
-$5K
Net cash flows used
in financing...
-$1,425K
Net cash flows used
in operating...
-$11K
Canceled cashflow
$7,908K
Canceled cashflow
$9,413K
Payments of notes payable
$8,883K
Net loss
-$7,492K
Payments of notes
payable, related party
$240K
Payments of convertible
notes
$210K
(gain) loss on leased
assets
$861K
Operating lease
liabilities
-$344K
Other liabilities
-$184K
Accounts receivable
$182K
Change in fair value of
conversion feature...
$162K
Prepaid expenses and
other current assets
$140K
Foreign exchange
adjustments
$38K
Inventories
$21K
Back
Back
Cash Flow
source: myfinsight.com
Emmaus Life Sciences, Inc. (EMMA)
Emmaus Life Sciences, Inc. (EMMA)